Loading…
← CockpitCompetitor Analysis › 300326.SZ Shanghai Kinetic Medical Co., Ltd. Class AOpen in the cockpit ↗

Shanghai Kinetic Medical Co., Ltd. Class A300326.SZCompetitor analysis, valuation and peers

China · CNY·Health Care›Medical Specialties
Momentum leader 86
Mkt cap
$662M
US dollars, full cap
Free float
94%
of shares outstanding
$/day
$8.33M
20-day average traded
Fwd P/E
26.0×
forward earnings
ROIC−WACC
+0.9 pp
WACC 8.3%
Hurdle
+9 pp
Req g minus delivered
Next earnings
159 days
26 Apr 2027
Close · CNYCN¥6.27
1D-1.6%
1W-5.1%
1M-4.3%
3M+3.0%
6M-9.8%
YTD+10.4%
1Y+6.8%
ATR %2.8%
52w lowhigh14.5% off high

What Shanghai Kinetic Medical does

Employees: 553

Shanghai Kinetic Medical at a glance

Size Shanghai Kinetic Medical (300326.SZ) is a China Health Care company (Medical Specialties) with a market value of $662M, the 3021st largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥6.27 on 18 Nov 2026.

Performance Over six months the shares fell 9.8%, against -10.0% for the median peer and -20.0% for the China market (cap-weighted) — 11th highest of 21 in its peer set.

Growth Revenue fell 28.1% over the last twelve months (peer median +17.0%); the operating margin is 17.1% (peer median 12.6%).

Valuation It trades at 26.0× forward earnings against a peer median of 26.7× (9th cheapest of 17).

Price implies For today's price to make sense, revenue must grow about 7% a year for seven years (Req g). Recent delivered growth is -2%, so the hurdle is +9 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 0.9 points above its cost of capital (8.3% WACC).

Next results Next results expected around 26 Apr 2027 (exchange calendar; dates can move).

Relative performance

809010021 May 202621 Aug 202618 Nov 2026300326.SZ 92Peer median 91
Six months, rebased to 100: Shanghai Kinetic Medical against the median of its 20 peers (local-currency closes).

Shanghai Kinetic Medical financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥734MCN¥960MCN¥979MCN¥949MCN¥1.16B
Revenue growth—-2%+3%-18%—
Gross profitCN¥504MCN¥468MCN¥446MCN¥444MCN¥695M
EBITDAn/aCN¥142MCN¥163MCN¥158MCN¥287M
Net incomeCN¥269MCN¥135M-CN¥106MCN¥113M-CN¥21.3M
Free cash flowCN¥249MCN¥144MCN¥94.6MCN¥230MCN¥203M
Capital expenditureCN¥21.8MCN¥66.2MCN¥82.8MCN¥53.8MCN¥41.5M
Total debtCN¥50.3MCN¥54.2MCN¥326MCN¥197MCN¥329M

Quarterly statements and history in the cockpit →

Shanghai Kinetic Medical competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%+100%-20%0%+20%SNTQDEL0028761789DCTH491000688389185830123415017575688410XVIVO301122MEDISGHT300326.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Shanghai Kinetic Medical is the large dot.

Fundamentals: revenue growth against valuation

-25%0%+25%+50%0×200×SNTQDEL0028761789DCTH688389688085185815017575300622301122NAN300326.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Shanghai Kinetic Medical is the large dot.

Capital: growth delivered against growth the price implies

0%+50%+100%0%50%100%SNT0028761789DCTH68838968808518583012341501688410XVIVONAN300326.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Shanghai Kinetic Medical is the large dot.

Shanghai Kinetic Medical competitors and peer comparison

How Shanghai Kinetic Medical compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Shanghai Kinetic Medical against its 20 peers (data as of 18 Nov 2026)
Measure300326.SZPeer medianRank in peer set
1-month return-4.3%-1.9%9th lowest of 21
6-month return-9.8%-10.0%11th highest of 21
Distance from 52-week high-14.5%-33.8%6th highest of 21
Revenue growth (TTM)-28.1%+17.0%lowest of 21
Operating margin17.1%12.6%9th highest of 21
Forward P/E26.0×26.7×9th cheapest of 17
Growth the price implies (Req g, 7 yrs)6.6%5.2%9th least demanding of 17
Growth delivered (Del g)-1.9%+14.3%lowest of 17
Hurdle (Req g minus delivered)+8.5 pp-11.7 pp4th most demanding of 17
ROIC minus cost of capital+0.9 pp+4.1 pp8th lowest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Shanghai Kinetic Medical 300326.SZChina$662M-10%-28%17%26.0×6.6%-1.9%
Synektik SNT.WAPoland$662M+10%+32%24%13.8×0.2%+47.5%
QuidelOrtho QDELUnited States$657M-20%-5%-2%10.7×n/an/a
Shenzhen Sunnypol Optoelectornics 002876.SZChina$680M-9%+29%5%39.0×10.1%+14.2%
AK Medical 1789.HKHong Kong$642M-23%+16%26%10.5×-11.5%+6.7%
Delcath Systems DCTHUnited States$685M+75%+38%5%358.9×33.4%+120.2%
Livsmed 491000.KSSouth Korea$687M-47%+89%-77%n/an/an/a
Shenzhen Lifotronic Technology 688389.SSChina$692M-14%+14%13%29.9×11.6%+13.3%
Shanghai Sanyou Medical 688085.SSChina$692M-23%+15%4%50.0×29.0%+6.8%
Beijing Chunlizhengda Medical Instruments 1858.HKHong Kong$631M-28%-9%31%8.5×-9.5%+1.5%
SunMax Biotechnology 4728.TWOTaiwan$630M0%+19%51%n/a-2.6%+18.8%
Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZChina$697M+148%-14%3%n/a31.8%-0.6%
Shanghai INT Medical Instruments 1501.HKHong Kong$700M-25%+35%21%15.9×-3.3%+23.5%
Japan Lifeline 7575.TJapan$703M+34%+6%19%14.5×-9.5%+2.9%
SWS Hemodialysis Care 688410.SSChina$706M-11%+31%19%23.5×16.2%+25.9%
Doctorglasses Chain 300622.SZChina$710M-22%+6%14%22.8×-3.4%+15.7%
Xvivo Perfusion XVIVO.STSweden$611M-32%+18%12%53.1×35.9%+35.2%
Caina Technology 301122.SZChina$721M+36%+61%0%55.4×n/an/a
Nanosonics NAN.AXAustralia$599M-4%+3%7%98.6×35.3%+6.7%
Medistim MEDI.OLNorway$599M+32%+19%29%31.8×-1.2%+14.5%
Sight Sciences SGHTUnited States$599M+122%+16%-30%n/an/an/a

Questions

Which companies are Shanghai Kinetic Medical's closest peers?
The cockpit's peer set: Synektik (SNT.WA), QuidelOrtho (QDEL), Shenzhen Sunnypol Optoelectornics (002876.SZ), AK Medical (1789.HK), Delcath Systems (DCTH), Livsmed (491000.KS), Shenzhen Lifotronic Technology (688389.SS), Shanghai Sanyou Medical (688085.SS).
Is Shanghai Kinetic Medical expensive compared with its peers?
On forward p/e it trades at 26.0× against a peer median of 26.7×, 9th cheapest of 17 in its peer set. For today's price to make sense, revenue must grow about 7% a year for seven years (Req g). Recent delivered growth is -2%, so the hurdle is +9 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Shanghai Kinetic Medical stock performed?
Over six months to 18 Nov 2026 the shares returned -9.8% against -10.0% for the median peer; over one year +6.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.